Literature DB >> 16287589

Early psoriatic arthritis.

David Kane1, Sanjay Pathare.   

Abstract

In the majority of patients with psoriatic arthritis (PsA), it is a chronic progressive disease, and only 12% of patients with early PsA will be in disease-modifying antirheumatic drug-free remission at 2 years. Radiologic damage occurs in the early stages of PsA; up to 47% of patients with PsA have radiologic erosions after 2 years. This article reviews the clinical features of early PsA, pathologic insights into PsA gleaned from studies of early PsA, and the current state of diagnostic imaging and therapeutics in early PsA.

Entities:  

Mesh:

Year:  2005        PMID: 16287589     DOI: 10.1016/j.rdc.2005.07.009

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  12 in total

1.  Ultrasound revealing subclinical enthesopathy at the greater trochanter level in patients with spondyloarthritis.

Authors:  Marwin Gutierrez; Filippo Luccioli; Fausto Salaffi; Elena Bartoloni; Chiara Bertolazzi; Vittorio Bini; Emilio Filipucci; Walter Grassi; Roberto Gerli
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

2.  Is remission a more realistic goal in psoriatic arthritis?

Authors:  Tajvur P Saber; Ursula Fearon; Douglas J Veale
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

3.  Spondyloarthritis: Closing the gap in psoriatic arthritis.

Authors:  Christopher Ritchlin
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 4.  Tumor necrosis factor inhibitors in psoriatic arthritis.

Authors:  Santhi Mantravadi; Alexis Ogdie; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2017-05-22       Impact factor: 5.045

5.  [Screening and early diagnosis of psoriasis arthritis].

Authors:  P Härle
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

Review 6.  Spondyloarthritis: clinical suspicion, diagnosis, and sports.

Authors:  Brock E Harper; John D Reveille
Journal:  Curr Sports Med Rep       Date:  2009 Jan-Feb       Impact factor: 1.733

7.  Remission in psoriatic arthritis: is it possible and how can it be predicted?

Authors:  Tajvur P Saber; C T Ng; Guillaume Renard; Bernadette M Lynch; Eliza Pontifex; Ceara A E Walsh; Alexia Grier; Marian Molloy; Barry Bresnihan; Oliver Fitzgerald; Ursula Fearon; Douglas J Veale
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

8.  [Detection of psoriasis arthritis with the GEPARD patient questionnaire in a dermatologic outpatient setting].

Authors:  P Härle; W Hartung; P Lehmann; B Ehrenstein; N Schneider; H Müller; U Müller-Ladner; I Tarner; T Vogt; M Fleck; T Bongartz
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

9.  Value of entheseal ultrasonography and serum cartilage oligomeric matrix protein in the preclinical diagnosis of psoriatic arthritis.

Authors:  Hanan Mohamed Farouk; Afaf Abdel Alim Mostafa; Sahar S Youssef; Moataz Mohammed Samy Elbeblawy; Naglaa Youssef Assaf; El Sayed E Elokda
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-03-29

10.  CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis.

Authors:  Yahui Grace Chiu; Tianmeng Shao; Changyong Feng; Kofi A Mensah; Michael Thullen; Edward M Schwarz; Christopher T Ritchlin
Journal:  Arthritis Res Ther       Date:  2010-01-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.